UBS Call 405 2FE 20.12.2024/ CH1329471010 /
27/05/2024 11:54:33 | Var.+0.040 | Denaro12:05:59 | Lettera12:05:59 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.760EUR | +1.47% | 2.750 Quantità in denaro: 2,500 |
2.800 Quantità in lettera: 2,500 |
FERRARI N.V. | 405.00 EUR | 20/12/2024 | Call |
GlobeNewswire
11:00
Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID...
GlobeNewswire
10:30
REPEAT - Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale B...
GlobeNewswire
10:00
Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Sub...